Myelin-Oligodendrocyte Glycoprotein
"Myelin-Oligodendrocyte Glycoprotein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transmembrane protein present in the MYELIN SHEATH of the CENTRAL NERVOUS SYSTEM. It is one of the main autoantigens implicated in the pathogenesis of MULTIPLE SCLEROSIS.
Descriptor ID |
D063308
|
MeSH Number(s) |
D12.776.395.550.114.500 D12.776.543.550.195.500 D12.776.543.620.550 D12.776.631.580.530 D23.050.422.625
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myelin-Oligodendrocyte Glycoprotein".
Below are MeSH descriptors whose meaning is more specific than "Myelin-Oligodendrocyte Glycoprotein".
This graph shows the total number of publications written about "Myelin-Oligodendrocyte Glycoprotein" by people in this website by year, and whether "Myelin-Oligodendrocyte Glycoprotein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2019 | 0 | 2 | 2 |
2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myelin-Oligodendrocyte Glycoprotein" by people in Profiles.
-
Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther. 2021 Dec 04; 12(1):594.
-
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Presentation, Diagnosis, and Management. Pediatr Ann. 2021 Jun; 50(6):e254-e258.
-
Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production. JCI Insight. 2019 04 02; 5.
-
Thymic regulatory T cells arise via two distinct developmental programs. Nat Immunol. 2019 02; 20(2):195-205.
-
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis. J Neuroimmunol. 2016 05 15; 294:32-40.
-
Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016 Jan; 19(1):65-74.
-
ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis. J Neurosci. 2015 Dec 02; 35(48):15921-33.
-
The kinase PKCa selectively upregulates interleukin-17A during Th17 cell immune responses. Immunity. 2013 Jan 24; 38(1):41-52.
-
Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A. 2008 Mar 11; 105(10):3915-20.
-
Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J Exp Med. 2007 Dec; 213(4):329-39.